Do you want to read an article? Please log in or register.
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial
Myocardial Infarction
Indications
Related content
Myocardial Infarction
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction
N Engl J Med
Ibanez B, Latini R, Rossello X, Dominguez-Rodriguez A, Fernández-Vazquez F, Pelizzoni V, Sánchez PL, Anguita M, Barrabés JA, Raposeiras-Roubín S, Pocock S, Escalera N, Staszewsky L, Pérez-García CN, Díez-Villanueva P, Pérez-Rivera JA, Prada-Delgado O, Owen R, Pizarro G, Caldes O, Gómez-Talavera S, Tuñón J, Bianco M, Zarauza J, Vetrano A, Campos A, Martínez-Huertas S, Bueno H, Puentes M, Grigis G, Bonilla-Palomas JL, Marco E, González-Juanatey JR, Bangueses R, González-Juanatey C, García-Álvarez A, Ruiz-García J, Carrasquer A, García-Rubira JC, Pascual-Figal D, Tomás-Querol C, San Román JA, Baratta P, Agüero J, Martín-Reyes R, Colivicchi F, Ortas-Nadal R, Bazal P, Cordero A, Fernández-Ortiz A, Basso P, González E, Poletti F, Bugani G, Debiasio M, Cosmi D, Navazio A, Bermejo J, Tortorella G, Marini M, Botas J, de la Torre-Hernández JM, Ottani F, Fuster V, REBOOT-CNIC Investigators
doi: 10.1056/NEJMoa2504735
Myocardial Infarction
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
N Engl J Med
Munkhaugen J, Kristensen AMD, Halvorsen S, Holmager T, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Mæng M, Vikenes K, Jensen SE, Steigen T, Lambrechtsen J, Jortveit J, Bovin A, Schirmer H, Christiansen MK, Wiseth R, Mikkelsen D, Larsen AI, Kjærgaard CL, Andresen K, Gustafsson I, Tuseth V, Larsen ML, Deeg PS, Veien K, Bøhmer E, Bøtker HE, Brattrud AO, Brønnum-Schou J, Pettersen AR, Bang LE, Øie E, Engstrøm T, Borg EB, Kristensen K, Nymo SH, Gislason G, Vethe NT, Abdulla JAM, Dammen T, Mouridsen MR, Bendz B, Bertelsen MLN, Hove JD, Schierbeck L, Snoer M, Davidsen C, Egholm G, Thomsen KK, Jadou G, Poenaru M, Krarup NT, Böttcher M, Stæhr PB, Zwisler AD, Edvardsen T, Torp-Pedersen C, Otterstad JE, Lange T, Fagerland MW, Atar D, Prescott E, BETAMI–DANBLOCK Investigators
doi: 10.1056/NEJMoa2505985
Myocardial InfarctionTherapy and Intervention
Effect of Red Blood Cell Transfusion Strategy on Clinical Outcomes Among Patients with Acute Myocardial Infarction Undergoing Revascularization: A Prespecified Analysis of the MINT Trial
Circ Cardiovasc Interv
Rao SV, Brooks MM, D'Agostino HEA, Steg PG, Simon T, Aronow HD, Goldsweig AM, Malik S, Alsweiler C, Ho KK, Dehghani P, Caixeta A, Quraishi AR, Robinson S, Traverse JH, Siddiqi O, Fergusson DA, Potter BJ, Schulman-Marcus J, Keating FK, Carson JL, MINT Trial Investigators
doi: 10.1161/CIRCINTERVENTIONS.125.015249
Myocardial Infarction
Early anti-inflammatory therapy in acute myocardial infarction: A network meta-analysis of timing-dependent effects in 23 randomized trials and 28,220 patients
Atherosclerosis
Rivero-Santana B, Saldaña-García J, Jurado-Román A, Cantolla-Pablo P, Gil-Fernández M, López-Sendón J, Tardif JC, Moreno R, Fernández-Velasco M
doi: 10.1016/j.atherosclerosis.2025.120443
Myocardial Infarction
Mineralocorticoid Receptor Antagonists in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Trials
JACC Heart Fail
d'Entremont MA, Cheema Z, Pitt B, Kedev S, Cornel JH, Stankovic G, Moreno R, Storey R, Bossard M, Chauhan A, Montalescot G, Beygui F, Zannad F, Jolly S, Mineralocorticoid Antagonist Post Myocardial Infarction Trialist Collaboration
doi: 10.1016/j.jchf.2025.102531
Myocardial Infarction
Selective C-reactive protein apheresis in ST-elevation myocardial infarction: Design and rationale of the randomized CRP-STEMI trial
Am Heart J
Reinstadler SJ, Kronbichler A, Reindl M, Tiller C, Holzknecht M, Oberhollenzer F, Kaser A, Gauckler P, Stiermaier T, Feistritzer HJ, Mayr A, Gizewski ER, Rezar R, Bugger H, Eller K, Eitel I, Schneider S, Mayer G, Thiele H, Bauer A, Metzler B, Lechner I, CRP-STEMI Investigators
doi: 10.1016/j.ahj.2025.07.067
Heart, Artery and Coronary DiseasesMyocardial InfarctionTherapy and Intervention
Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Design of the AMUNDSEN Trial
Am Heart J
Montalescot G, Bolognese L, Bartus S, Cequier-Fillat A, Thiele H, Mach F, Jukema JW, Ferrari E, Souteyrand G, Bouleti C, Range G, Chioccioli M, Picchi A, Batias-Moreau L, Esposito G, Braik N, Redjimi N, Duband B, Guedeney P, Zeitouni M, Brochard K, Silvain J, Vicaut E, AMUNDSEN investigators of the ACTION Study Group
doi: 10.1016/j.ahj.2025.107295
Heart, Artery and Coronary DiseasesMyocardial Infarction
Complete versus culprit lesion-only revascularisation for acute myocardial infarction (Complete Revascularisation Trialists' Collaboration): an individual patient data meta-analysis of randomised trials
Lancet
Mehta SR, Tiong DTW, Böhm F, Ramasundarahettige C, Biscaglia S, Campo G, James S, Smits PC, Giacoppo D, McCann GP, Banning A, Høfsten DE, Casella G, Kirabo FR, Nguyen H, Wood DA, Cairns JA, Engstrøm T
doi: 10.1016/S0140-6736(25)02170-1
Myocardial Infarction
Multivitamins After Myocardial Infarction in Patients With Diabetes: A Randomized Clinical Trial
JAMA Intern Med
Ujueta F, Lamas GA, Anstrom KJ, Navas-Acien A, Boineau R, Rosenberg Y, Stylianou M, Jones TLZ, Joubert BR, Yu Q, Wen J, Nemeth H, Huang Z, Fonseca V, Nathan DM, Uwaifo G, Arenas IA, Luo L, Baker J, Visentin D, Paixao A, Schmedtje JF Jr, Mark DB, TACT2 Investigators
doi: 10.1001/jamainternmed.2024.8408